Pzena Investment Management LLC Buys Shares of 1,157,273 Envista Holdings Corporation $NVST

Pzena Investment Management LLC bought a new stake in Envista Holdings Corporation (NYSE:NVST) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,157,273 shares of the company’s stock, valued at approximately $30,494,000. Pzena Investment Management LLC owned approximately 0.71% of Envista at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in NVST. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Envista in the 2nd quarter valued at $25,000. Caitong International Asset Management Co. Ltd boosted its stake in Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after purchasing an additional 1,504 shares during the last quarter. Allworth Financial LP boosted its stake in Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after purchasing an additional 776 shares during the last quarter. UMB Bank n.a. grew its holdings in shares of Envista by 46.1% during the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after buying an additional 636 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after buying an additional 949 shares in the last quarter.

Analyst Ratings Changes

Several equities analysts have recently weighed in on NVST shares. Piper Sandler reissued a “neutral” rating and issued a $28.00 price target (up from $26.00) on shares of Envista in a research note on Thursday, August 6th. Evercore reiterated an “outperform” rating and issued a $33.00 price objective on shares of Envista in a report on Thursday, May 7th. JPMorgan Chase & Co. raised their target price on shares of Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Morgan Stanley set a $23.00 target price on shares of Envista in a research note on Thursday, August 6th. Finally, Zacks Research upgraded Envista from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $29.31.

Envista Price Performance

NYSE:NVST opened at $27.68 on Tuesday. Envista Holdings Corporation has a 52 week low of $18.77 and a 52 week high of $30.42. The stock’s fifty day moving average is $26.66 and its two-hundred day moving average is $26.19. The company has a market capitalization of $4.45 billion, a P/E ratio of 47.72, a P/E/G ratio of 1.34 and a beta of 0.86. The company has a quick ratio of 2.07, a current ratio of 2.43 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The business had revenue of $730.50 million during the quarter, compared to analysts’ expectations of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.The company’s revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the business posted $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Equities analysts expect that Envista Holdings Corporation will post 1.53 EPS for the current year.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.